May 22, 2017 by Chain Drug Review
Centers for Medicare & Medicaid Services, H.R. 1038, H.R. 1316, H.R. 1939, H.R. 592, independent community pharmacies, Medicare, National Community Pharmacists Association, NCPA
Leading Headlines, Pharmacy, Retail News
ALEXANDRIA, Va. — The National Community Pharmacists Association urged leaders in the House of Representatives to enact a slate of bills that would foster access to pharmacy services in Medicare. NCPA said Monday that it submitted comments for a House Ways and Means Health Subcommittee hearing on Medicare and offered suggestions to enhance the program
March 13, 2017 by Mark Baumgartner and Chain Drug Review
Affordable Care Act, Centers for Medicare & Medicaid Services, CMS, health expenditures in the United States, U.S. health care spending
2017, Issue 03-13-2017, Issues, News
WASHINGTON — The pace of growth in U.S. health care spending is expected to quicken this year, increasing 5.4% over 2016, according to a report by the Centers for Medicare & Medicaid Services (CMS). Health care spending last year hit $3.4 trillion, an amount that represents a 4.8% increase from 2015, CMS said in a
February 16, 2017 by Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, Community Oncology Alliance, CVS Health, DIR fees, direct and indirect remuneration, H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act, Medicare Part D, Morgan Griffith, National Community Pharmacists Association, PBM industry, Peter Welch, Pharmaceutical Care Management Association
Featured Articles, Leading Headlines, Pharmacy, Retail News
WASHINGTON — Reps. Morgan Griffith (R., Va.) and Peter Welch (D., Vt.) have reintroduced the Improving Transparency and Accuracy in Medicare Part D Spending Act (H.R. 1038), which community pharmacies say would squelch a growing burden: retroactive direct and indirect remuneration (DIR) fees. The bill, introduced Wednesday in the House of Representatives, would ban the application
January 2, 2017 by Geoff Walden and Chain Drug Review
Affordable Care Act, Andy Slavitt, Centers for Medicare & Medicaid Services, Council of Economic Advisers, Department of Health and Human Services, health insurance, Jason Furman, Kevin Brady, Obamacare, President-elect Donald Trump’s inauguration, Sylvia Burwell
2017, Issue 01-02-2017, Issues, News
WASHINGTON — Republicans want to replace the Affordable Care Act with “universal access” to health care, House GOP members said. The goal is to ensure that everyone can buy or find coverage, a House leadership aide said at a briefing organized by top Republicans. The briefing came amid growing concern about the 20 million people
December 12, 2016 by Geoff Walden and Chain Drug Review
ACA, Affordable Care Act, Centers for Medicare & Medicaid Services, CMS, Department of Health and Human Services, Donald Trump, HHS, National Association of Chain Drug Stores, Obamacare, Seema Verma, Steve Anderson, Tom Price
2016, Issue 12-12-2016, Issues, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — The choices of Tom Price and Seema Verma for top health positions under Donald Trump have reaffirmed the president-elect’s commitment to toppling the Affordable Care Act. Price, a six-term Republican congressman from Georgia and fierce critic of Obamacare, was picked as secretary of the Department of Health and Human Services (HHS), while Verma,
December 12, 2016 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, Centers for Medicare & Medicaid Services, Health and Human Services, Jeffrey Woldt, Martin Otto, NACDS, NACDS Foundation Dinner, NACDS Week in New York, National Association of Chain Drug Stores, Seema Verma, Steve Anderson, Tom Price
2016, Issue 12-12-2016, Issues, Opinion
At the start of the month the National Association of Chain Drug Stores concluded a series of successful events in the nation’s economic and cultural capital. The much anticipated annual gathering, known as NACDS Week in New York, brings together leaders from the diverse constituents that comprise the chain pharmacy industry to take stock as
November 30, 2016 by Chain Drug Review
Affordable Care Act, Centers for Medicare & Medicaid Services, CMS adminstrator, Donald Trump, HHS secretary, NACDS, National Association of Chain Drug Stores, Seema Verma, Steve Anderson, Tom Price, U.S. Department of Health and Human Services
Featured Articles, Leading Headlines, Pharmacy, Retail News
ARLINGTON, Va. — The National Association of Chain Drug Stores said it’s ready to work with President-elect Donald Trump’s nominees to lead the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS). Trump on Tuesday named U.S. Rep. Tom Price (R., Ga.) as HHS secretary and Seema
September 7, 2016 by Chain Drug Review
Centers for Medicare & Medicaid Services, CVS Health, CVS Pharmacy, Kevin Counihan, Project Health, Troyen Brennan, video
Leading Headlines, Retail News, Videos
WOONSOCKET, R.I. — CVS Health has kicked off Project Health, its annual campaign to foster access to primary care and promote a preventive approach to health care. CVS said Wednesday that, from Sept. 8 to Dec. 18, it will provide nearly $8 million of free health services through more than 500 Project Health events at
August 12, 2016 by CDR Blog and Chain Drug Review
Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, National Community Pharmacists Association, NCPA, Ralph Abraham, Seth Moulton, William Keating
CDR Blog
Persistence is paying off for the National Community Pharmacists Association in its advocacy for more transparency with DIR fees. In a posting in its “The Dose” blog this week, NCPA noted that it continues to build congressional support in getting the Centers for Medicare & Medicaid Services (CMS) to finalize its guidance on direct and
August 1, 2016 by John Shakow and Chain Drug Review
Centers for Medicare & Medicaid Services, chain drug stores, final AMP rule, John Shakow, King & Spalding, Medicaid Drug Rebate Program, multisource drug, pharmacy reimbursement, Retail Community Pharmacies
Leading Headlines, Opinion
On February 1, 2016, the Centers for Medicare & Medicaid Services (CMS) released its Final Rule interpreting the provisions of the 2010 health care reform law that address the Medicaid Drug Rebate Program (MDRP). While much of the Final Rule speaks to drug manufacturer rights and responsibilities in the MDRP, significant portions are directly applicable
July 25, 2016 by Greg Jacobson and Chain Drug Review
Centers for Medicare & Medicaid Services, CMS, health care spending in the United States, National Health Expenditure Projections 2015–25, Sean Keehan
2016, Issue 07-25-2016, Issues, News
WASHINGTON — A new study by personnel of the Centers for Medicare & Medicaid Services (CMS) projects that health care spending in the United States will exceed $10,000 per person this year. The report, published in the health policy journal Health Affairs, predicts that health care spending growth is accelerating after several years of unusually
June 22, 2016 by Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, CMS, DIR fees, Medicare Part D, National Community Pharmacists Association, NCPA
Leading Headlines, Pharmacy, Retail News
ALEXANDRIA, Va. — Nearly 50 members of Congress have called on the Centers for Medicare & Medicaid Services (CMS) to finalize its proposed guidance on how Medicare Part D sponsors report pharmacy price concessions, also known as direct and indirect remuneration (DIR) fees. The National Community Pharmacists Association said that 16 senators and 30 representatives
May 19, 2016 by Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, CMS, DIR fees, National Community Pharmacists Association, NCPA
Leading Headlines, Pharmacy, Retail News
ALEXANDRIA, Va. — The National Community Pharmacists Association has joined with a group of pharmacy industry stakeholders in calling for more clarity about direct and indirect (DIR) fees. NCPA said that this week it teamed up with 21 other organizations — including drug chains, drug suppliers, drug cooperatives and pharmacy associations, among others — in
March 8, 2016 by CDR Blog
Centers for Medicare & Medicaid Services, CMS, Covered Outpatient Drugs final rule, final AMP-based FULs, Medicaid Drug Rebate Program, Medicaid drug reimbursement, NACDS, National Association of Chain Drug Stores
CDR Blog
The National Association of Chain Drug Stores reports that final average manufacturer price (AMP)-based federal upper limits (FULs) are set to be published by the Centers for Medicare & Medicaid Services (CMS) late this month. Once instituted, the final AMP-based FULs will “significantly change” Medicaid pharmacy reimbursement for branded and generic drugs, according to NACDS.